Table 5.
Correlation between miRNA expression levels and clinical variables in triple negative breast cancers
| |
Age at diagnosis |
Tumour size (mm) |
% + ve lymph nodes |
|||
|---|---|---|---|---|---|---|
| Spearman rank | p-value | Spearman rank | p-value | Spearman rank | p-value | |
|
let-7a |
0.04597 |
0.7932 |
0.07885 |
0.6525 |
−0.2904 |
0.0906 |
|
let-7b |
−0.08997 |
0.6073 |
0.08432 |
0.6301 |
−0.3324 |
0.0511 |
|
miR-100 |
−0.09418 |
0.5905 |
0.171 |
0.3259 |
−0.1892 |
0.2764 |
|
miR-101 |
0.1756 |
0.313 |
0.17 |
0.3288 |
−0.4355 |
0.0089 |
|
miR-126* |
0.0471 |
0.7882 |
0.08945 |
0.6093 |
−0.1581 |
0.3643 |
|
miR-130a |
0.07147 |
0.6833 |
−0.1973 |
0.256 |
−0.2539 |
0.1411 |
|
miR-210 |
0.1029 |
0.5565 |
0.004349 |
0.9802 |
−0.09827 |
0.5744 |
|
miR-26a |
0.05199 |
0.7668 |
0.08586 |
0.6238 |
−0.1696 |
0.3301 |
|
miR-26b |
0.1511 |
0.3863 |
0.05724 |
0.744 |
−0.1778 |
0.3068 |
| miR-29c | 0.07231 | 0.6797 | 0.1254 | 0.4728 | −0.3131 | 0.0671 |
Values represent Spearman’s rank correlation coefficient and significant correlations (p < 0.05) are shown in bold.